Spectrum, VC Poised To Control HealthMEDX

Buyout shop Spectrum Equity and venture capital firm Trident Capital are expected to invest $56 million in health care software company HealthMEDX Inc. for a controlling stake, sources close to the matter told sister news service Reuters. An announcement could come soon, the sources said.

As part of the investment, Pamela Pure, former president of McKesson Technology Solutions, will join HealthMEDX as chief executive officer. Vince Estrada, former CFO of health care IT vendor Visicu Inc., will join as CFO of HealthMEDX, the sources said. Visicu was sold to Philips Electronics for $430 million in 2007.

HealthMEDX’s three co-founders will take on a variety of executive and strategic roles, including Charlie Daniels, who will remain president, according to the sources. The company, which serves as a technology platform to manage patients in a post-acute care environment, will have a five-member board, including Pure, two senior representatives from Spectrum, and two Trident managing directors, the sources said.

Talks between Pure, Trident and HealthMEDX took off in July over the investment, and in September Spectrum was brought on board, the sources said. Both firms also own several other technology companies in health care and will act as potential partners with HealthMedx over time. Representatives for HealthMEDX, Trident and Spectrum declined to comment.

(Nadia Damouni is a reporter for Reuters in New York.)